|
|
||||||||
Office of the Medical Investigator, University of New Mexico School of Medicine, Albuquerque, NM, Formerly: Office of the Chief Medical Examiner, State of Connecticut, Farmington, CT (Dr. Nolte)
Department of Neurology, Yale Stroke Program, Yale University School of Medicine, New Haven, CT (Dr. Brass)
Office of the Medical Examiner, State of Connecticut, Farmington, CT. (Ms. Fletterick)
Address correspondence and reprint requests to Dr. Kurt B. Nolte, Office of the Medical Investigator, University of New Mexico School of Medicine, Albuquerque, NM 87131-5091.
Objectives: To determine the incidence of cocaine abuse in cases of fatal intracranial hemorrhage and to examine potential pathophysiologic mechanisms.
Design: Prospective clinical, autopsy, and toxicologic evaluation of all cases of fatal non-traumatic intracranial hemorrhage examined during 1 year (April 11, 1989 to April 10, 1990) at the Connecticut Office of the Chief Medical Examiner. Autopsy examination included exhaustive histologic evaluation of cerebral vessels and parenchyma for vasculitis and other vasculopathies.
Results: Ten of 17 (59%) of all non-traumatic intracranial hemorrhages were associated with a positive toxicology for cocaine. Seven (70%) of these were parenchymal hemorrhages, and the remaining three (30%) were subarachnoid hemorrhages (ruptured berry aneurysms). No vasculitis or other vasculopathy was identified.
Conclusions: These findings implicate cocaine use as a significant risk factor for fatal brain hemorrhage and may explain, in part, the increased incidence of hemorrhagic stroke in some drug-using cohorts. The lack of specific pathologic findings suggests that cocaine-associated intracranial hemorrhages are a consequence of the pharmacodynamic effect of cocaine and not a cocaine-induced vasculopathy.
Received July 6, 1995. Accepted in final form October 16, 1995.
This article has been cited by other articles:
![]() |
S. D Treadwell and T. G Robinson Cocaine use and stroke Postgrad. Med. J., June 1, 2007; 83(980): 389 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Westover, S. McBride, and R. W. Haley Stroke in Young Adults Who Abuse Amphetamines or Cocaine: A Population-Based Study of Hospitalized Patients Arch Gen Psychiatry, April 1, 2007; 64(4): 495 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Calabrese, D. W. Dodick, T. J. Schwedt, and A. B. Singhal Narrative Review: Reversible Cerebral Vasoconstriction Syndromes Ann Intern Med, January 2, 2007; 146(1): 34 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Tacker, N. K. Herzog, and A. O. Okorodudu Cocaethylene Affects Human Microvascular Endothelial Cell p38 Mitogen-Activated Protein Kinase Activation and Nuclear Factor-{kappa}B DNA-Binding Activity Clin. Chem., October 1, 2006; 52(10): 1926 - 1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Bateman, H. C. Schumacher, C. D. Bushnell, J. Pile-Spellman, L. L. Simpson, R. L. Sacco, and M. F. Berman Intracerebral hemorrhage in pregnancy: Frequency, risk factors, and outcome Neurology, August 8, 2006; 67(3): 424 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Broderick, C. M. Viscoli, T. Brott, W. N. Kernan, L. M. Brass, E. Feldmann, L. B. Morgenstern, J. L. Wilterdink, and R. I. Horwitz Major Risk Factors for Aneurysmal Subarachnoid Hemorrhage in the Young Are Modifiable Stroke, June 1, 2003; 34(6): 1375 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van Gijn and G. J. E. Rinkel Subarachnoid haemorrhage: diagnosis, causes and management Brain, February 1, 2001; 124(2): 249 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Storen, E. F.M. Wijdicks, B. A. Crum, and G. Schultz Moyamoya-like Vasculopathy from Cocaine Dependency AJNR Am. J. Neuroradiol., June 1, 2000; 21(6): 1008 - 1010. [Abstract] [Full Text] |
||||
![]() |
A. W McEvoy, N. D Kitchen, and D. G T Thomas Lesson of the week: Intracerebral haemorrhage in young adults: the emerging importance of drug misuse BMJ, May 13, 2000; 320(7245): 1322 - 1324. [Full Text] |
||||
![]() |
J. W. Lipton, K. P. Mangan, and J. M. Silvestri Acute Cocaine Toxicity: Pharmacology and Clinical Presentations in Adult and Pediatric Populations Journal of Pharmacy Practice, April 1, 2000; 13(2): 159 - 169. [Abstract] [PDF] |
||||
![]() |
G. Bartzokis, I. B. Goldstein, D. B. Hance, M. Beckson, D. Shapiro, P. H. Lu, N. Edwards, J. Mintz, and P. Bridge The Incidence of T2-Weighted MR Imaging Signal Abnormalities in the Brain of Cocaine-Dependent Patients Is Age-Related and Region-Specific AJNR Am. J. Neuroradiol., October 1, 1999; 20(9): 1628 - 1635. [Abstract] [Full Text] |
||||
![]() |
M. J. Kaufman, J. M. Levin, M. H. Ross, N. Lange, S. L. Rose, T. J. Kukes, J. H. Mendelson, S. E. Lukas, B. M. Cohen, and P. F. Renshaw Cocaine-Induced Cerebral Vasoconstriction Detected in Humans With Magnetic Resonance Angiography JAMA, February 4, 1998; 279(5): 376 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
Cocaine May Be a Frequent Cause of Brain Hemorrhage Journal Watch Psychiatry, August 1, 1996; 1996(801): 2 - 2. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |